685 related articles for article (PubMed ID: 33200838)
21. Update on the pathogenesis of vitiligo.
Marchioro HZ; Silva de Castro CC; Fava VM; Sakiyama PH; Dellatorre G; Miot HA
An Bras Dermatol; 2022; 97(4):478-490. PubMed ID: 35643735
[TBL] [Abstract][Full Text] [Related]
22. Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review.
Białczyk A; Wełniak A; Kamińska B; Czajkowski R
Mol Diagn Ther; 2023 Nov; 27(6):723-739. PubMed ID: 37737953
[TBL] [Abstract][Full Text] [Related]
23. The Role of Regulatory Cell Death in Vitiligo.
Liu LY; He SJ; Chen Z; Ge M; Lyu CY; Gao D; Yu JP; Cai MH; Yuan JX; Zhang JL
DNA Cell Biol; 2024 Feb; 43(2):61-73. PubMed ID: 38153369
[TBL] [Abstract][Full Text] [Related]
24. New insights into immune mechanisms of vitiligo.
Boniface K; Taïeb A; Seneschal J
G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
[TBL] [Abstract][Full Text] [Related]
25. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
[TBL] [Abstract][Full Text] [Related]
26. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
Tulic MK; Cavazza E; Cheli Y; Jacquel A; Luci C; Cardot-Leccia N; Hadhiri-Bzioueche H; Abbe P; Gesson M; Sormani L; Regazzetti C; Beranger GE; Lereverend C; Pons C; Khemis A; Ballotti R; Bertolotto C; Rocchi S; Passeron T
Nat Commun; 2019 May; 10(1):2178. PubMed ID: 31097717
[TBL] [Abstract][Full Text] [Related]
27. RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis.
Sastry KS; Naeem H; Mokrab Y; Chouchane AI
Oxid Med Cell Longev; 2019; 2019():2841814. PubMed ID: 31871544
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes.
Zhang Y; Liu L; Jin L; Yi X; Dang E; Yang Y; Li C; Gao T
J Invest Dermatol; 2014 Jan; 134(1):183-191. PubMed ID: 23771121
[TBL] [Abstract][Full Text] [Related]
29. Vitiligo Pathogenesis and Emerging Treatments.
Rashighi M; Harris JE
Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
[TBL] [Abstract][Full Text] [Related]
30. The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response.
He S; Xu J; Wu J
Oxid Med Cell Longev; 2022; 2022():8796735. PubMed ID: 35096274
[TBL] [Abstract][Full Text] [Related]
31. IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo.
Willemsen M; Krebbers G; Tjin EPM; Willemsen KJ; Louis A; Konijn VAL; Narayan VS; Post NF; Bakker WJ; Melief CJM; Bekkenk MW; Luiten RM
Exp Dermatol; 2022 Apr; 31(4):556-566. PubMed ID: 34758170
[TBL] [Abstract][Full Text] [Related]
32. Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte.
Ng CY; Chan YP; Chiu YC; Shih HP; Lin YN; Chung PH; Huang JY; Chen HK; Chung WH; Ku CL
J Dermatol Sci; 2023 Jun; 110(3):78-88. PubMed ID: 37221109
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing.
Zhang J; Xiang F; Ding Y; Hu W; Wang H; Zhang X; Lei Z; Li T; Wang P; Kang X
BMC Genomics; 2024 Mar; 25(1):236. PubMed ID: 38438962
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo.
Shi Q; Zhang W; Guo S; Jian Z; Li S; Li K; Ge R; Dai W; Wang G; Gao T; Li C
Cell Death Differ; 2016 Mar; 23(3):496-508. PubMed ID: 26315342
[TBL] [Abstract][Full Text] [Related]
35. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.
Chang WL; Ko CH
Cells; 2023 Mar; 12(6):. PubMed ID: 36980277
[TBL] [Abstract][Full Text] [Related]
36. Occludin Promotes Adhesion of CD8
Zou P; Xiao Y; Deng Q; Shi Y; You R; Pi Z; Liu J; Zhan Y; Zeng Q; Zeng Z; Xiao R
Oxid Med Cell Longev; 2022; 2022():6732972. PubMed ID: 35222802
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of glutamine on human melanocyte oxidative stress model.
Jiang L; Guo Z; Kong Y; Liang J; Wang Y; Wang K
Indian J Dermatol Venereol Leprol; 2018; 84(3):269-274. PubMed ID: 29491190
[TBL] [Abstract][Full Text] [Related]
38. The Role of the NKG2D in Vitiligo.
Plaza-Rojas L; Guevara-Patiño JA
Front Immunol; 2021; 12():624131. PubMed ID: 33717132
[TBL] [Abstract][Full Text] [Related]
39. The enigma and challenges of vitiligo pathophysiology and treatment.
Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
[TBL] [Abstract][Full Text] [Related]
40. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
Garbelli S; Mantovani S; Palermo B; Giachino C
Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
